(Q48143905)

9 February 2018

title

Conformal radiation therapy treatment planning reduces the dose to the optic structures for patients with tumors of the paranasal sinuses. (English)

1 reference

9 February 2018

0 references

Brizel DM

1

1 reference

9 February 2018

Light K

series ordinal

2

1 reference

9 February 2018

Zhou SM

series ordinal

3

1 reference

9 February 2018

Marks LB

series ordinal

4

1 reference

9 February 2018

publication date

1 June 1999

1 reference

9 February 2018

Radiotherapy and Oncology

published in

1 reference

9 February 2018

volume

51

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

215-218

1 reference

9 February 2018

Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

Image registration: an essential part of radiation therapy treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

Dose volume histograms in treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

3-D conformal radiotherapy in head and neck cancer. The Washington University experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2899%2900043-2

7 January 2021

10.1016/S0167-8140(99)00043-2

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10435816

1 reference

9 February 2018